Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines (Q43746561)

26 November 2017

1 reference

title

Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines (English)

1 reference

26 November 2017

1 reference

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

issue

14-15

1 reference

26 November 2017

page(s)

1423-1432

1 reference

Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Influenza in children. Relationship to other respiratory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Epidemiology of acute lower respiratory disease in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

The Tecumseh study of respiratory illness. V. Patterns of infection with the parainfluenzaviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Immunity to and frequency of reinfection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Evaluation of Two Live, Cold‐Passaged, Temperature‐Sensitive Respiratory Syncytial Virus Vaccines in Chimpanzees and in Human Adults, Infants, and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

An outbreak of respiratory syncytial virus in a bone marrow transplant center

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory syncytial viral infection in children with compromised immune function

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory syncytial virus infection in immunocompromised adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Influenza among hospitalized adults with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Epidemiology of Influenza A virus infection in patients with acute or chronic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Parainfluenza virus infection in adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cell-mediated immunity in RSV bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cell-mediated immune response to respiratory syncytial virus infection: Relationship to the development of reactive airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cell-mediated immunity in respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Characterization of the human peripheral blood effector cells mediating antibody-dependent cell-mediated cytotoxicity against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Declining T-cell immunity to influenza, 1977-82

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cytotoxic T-cell immunity to influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory syncytial virus-specific immunoglobulins in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Neonatal respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Influence of immunological factors in respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Maternal antibody and respiratory syncytial virus infection in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Protection of infants from infection with influenza A virus by transplacentally acquired antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Breast-feeding and respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Secretion of respiratory syncytial virus inhibitors and antibody in human milk throughout lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cellular and antibody response to respiratory syncytial (rs) virus in human colostrum, maternal blood, and cord blood

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Immunoglobulin A antibody response to respiratory syncytial virus structural proteins in colostrum and milk

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Breast-feeding protects against respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

The Immunologic Response to Infection with Respiratory Syncytial Virus in Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Secretory immunological response in infants and children to parainfluenza virus types 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Antibodies to respiratory syncytial virus polypeptides and their significance in human infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Immunoglobulin-class-specific immune response to respiratory syncytial virus structural proteins in infants, children, and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Different kinetics of antibody responses between IgA and IgG classes in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Detection of RS-virus IgG-subclass-specific antibodies: variation according to age in infants and small children and diagnostic value in RS-virus-infected small infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Respiratory syncytial virus-specific IgE responses following infection: evidence for a predominantly mucosal response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Individuals infected with two subtypes of influenza A virus in the same season

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Differing virulence of H1N1 and H3N2 influenza strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Reinfection with Influenza A (H3N2) Virus in Young Children and Their Families

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Variation in frequency of natural reinfection with influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Comparison of monovalent and trivalent live attenuated influenza vaccines in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Development and characterization of cold-adapted viruses for use as live virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Live attenuated influenza A virus vaccines in children: results of a field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900103-0

7 January 2021

10.1016/S0264-410X(98)00103-0

Identifiers

DOI

1 reference

26 November 2017

1 reference